GR910100319A - Μέ?οδος για την παρασκευή στερεών συν?έσεων περιλαμβανουσών ευαισ?ητοποιημένο εις το φως και δυσκόλως υδατοδιαλυτό ενεργό συστατικό. - Google Patents

Μέ?οδος για την παρασκευή στερεών συν?έσεων περιλαμβανουσών ευαισ?ητοποιημένο εις το φως και δυσκόλως υδατοδιαλυτό ενεργό συστατικό.

Info

Publication number
GR910100319A
GR910100319A GR910100319A GR910100319A GR910100319A GR 910100319 A GR910100319 A GR 910100319A GR 910100319 A GR910100319 A GR 910100319A GR 910100319 A GR910100319 A GR 910100319A GR 910100319 A GR910100319 A GR 910100319A
Authority
GR
Greece
Prior art keywords
solid compositions
preparing solid
soluble
optionally
active ingredient
Prior art date
Application number
GR910100319A
Other languages
English (en)
Other versions
GR1002175B (en
Inventor
Rita Balazs
Margit Dr Csorgo
Attila Dr Mandi
Judit Marcisz
Margit Dr Nagy
Eva Judit Tajthy
Katalin Wagner
Original Assignee
Egyt Gyogyszervegyeszeti Gyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egyt Gyogyszervegyeszeti Gyar filed Critical Egyt Gyogyszervegyeszeti Gyar
Publication of GR910100319A publication Critical patent/GR910100319A/el
Publication of GR1002175B publication Critical patent/GR1002175B/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A61K9/4825—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Abstract

Η παρούσα εφεύρεσις αναφέρεται εις στερεάς φαρμακευτικάς συνθέσεις, κατά προτίμησιν κάψουλες μαλακής ζελατίνης, περιλαμβανούσας φωτο-ευαίσθητον δραστικόν συστατικόν όντος προαιρετικώς μόλις διαλυτόν εις ύδωρ, κατά προτίμησιν νιφεδιπίνη ω
GR910100319A 1990-07-20 1991-07-19 Method for preparing solid compositions GR1002175B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU904564A HUT59592A (en) 1990-07-20 1990-07-20 Process for the preparation of solid medical products

Publications (2)

Publication Number Publication Date
GR910100319A true GR910100319A (el) 1992-08-26
GR1002175B GR1002175B (en) 1996-03-07

Family

ID=10968329

Family Applications (1)

Application Number Title Priority Date Filing Date
GR910100319A GR1002175B (en) 1990-07-20 1991-07-19 Method for preparing solid compositions

Country Status (22)

Country Link
JP (1) JPH04253924A (el)
KR (1) KR920002162A (el)
BE (1) BE1006829A3 (el)
CA (1) CA2047482A1 (el)
CH (1) CH681960A5 (el)
CY (1) CY1840A (el)
CZ (1) CZ280064B6 (el)
DE (1) DE4124081A1 (el)
DK (1) DK137591A (el)
ES (1) ES2039177B1 (el)
FI (1) FI913493A (el)
FR (1) FR2664814B1 (el)
GB (1) GB2246072B (el)
GR (1) GR1002175B (el)
HU (1) HUT59592A (el)
IL (1) IL98894A0 (el)
IT (1) IT1250681B (el)
NL (1) NL9101268A (el)
SE (1) SE9102160L (el)
TW (1) TW203012B (el)
YU (1) YU47573B (el)
ZA (1) ZA915677B (el)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9411115D0 (en) * 1994-06-03 1994-07-27 Secr Defence Stabilisation of photosensitive material
UA42739C2 (uk) * 1995-04-24 2001-11-15 Пфайзер Інк. Спосіб інгібування фоторозкладу фармацевтично активних сполук, таблетка та капсула, що їх містять
DE19912623A1 (de) * 1999-03-20 2000-09-28 Lohmann Therapie Syst Lts Verfahren zur Erhöhung der Stabilität bei Lagerung und/oder Anwendung lichtempfindlicher therapeutischer Systeme oder deren Bestandteile
JP3549522B1 (ja) * 2003-10-24 2004-08-04 日清ファルマ株式会社 コエンザイムｑ１０含有カプセル剤
CN102164606B (zh) * 2008-09-30 2014-04-16 电气化学工业株式会社 光稳定化药物组合物
CA2968861C (en) 2017-05-30 2022-10-11 University Of Saskatchewan Topical nifedipine formulations and uses thereof
KR200489660Y1 (ko) * 2018-02-09 2019-07-19 김순희 퍼팅연습기

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2451934A1 (fr) * 1979-03-23 1980-10-17 Chugai Pharmaceutical Co Ltd Revetement de gelatine coloree
JPS55161863A (en) * 1979-06-06 1980-12-16 Paaku Deebisu Kk Colored gelatin capsule
EP0143857A1 (de) * 1983-11-30 1985-06-12 Siegfried Aktiengesellschaft Coronartherapeutikum in Form von Weichgelatine-Kapseln
WO1987000429A1 (en) * 1985-07-25 1987-01-29 Deutsche Gelatine-Fabriken Stoess & Co. Gmbh Opaque light-stable and possibly coloured gelatine products and method for their production
EP0221277A2 (de) * 1985-09-10 1987-05-13 Bayer Ag Beta-Carotin enthaltende Gelatine
EP0272336A1 (de) * 1986-12-18 1988-06-29 Kurt H. Prof. Dr. Bauer Gegenüber Lichteinfluss stabilisiertes Nifedipin-Konzentrat und Verfahren zu seiner Herstellung

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6043046B2 (ja) * 1979-04-24 1985-09-26 パ−ク・デ−ビス・エンド・コンパニ− ゼラチンカプセル
JPS61225109A (ja) * 1985-03-29 1986-10-06 Shiseido Co Ltd カラメル含有組成物
US4689233A (en) * 1986-01-06 1987-08-25 Siegfried Aktiengesellschaft Coronary therapeutic agent in the form of soft gelatin capsules
JPS63215641A (ja) * 1987-03-05 1988-09-08 Toyo Jozo Co Ltd ゼラチン皮膜組成物
JPH01218573A (ja) * 1988-02-25 1989-08-31 Yoshio Tanaka ドナリエラ藻体含有固形状食品の製造法

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2451934A1 (fr) * 1979-03-23 1980-10-17 Chugai Pharmaceutical Co Ltd Revetement de gelatine coloree
JPS55161863A (en) * 1979-06-06 1980-12-16 Paaku Deebisu Kk Colored gelatin capsule
EP0143857A1 (de) * 1983-11-30 1985-06-12 Siegfried Aktiengesellschaft Coronartherapeutikum in Form von Weichgelatine-Kapseln
WO1987000429A1 (en) * 1985-07-25 1987-01-29 Deutsche Gelatine-Fabriken Stoess & Co. Gmbh Opaque light-stable and possibly coloured gelatine products and method for their production
EP0221277A2 (de) * 1985-09-10 1987-05-13 Bayer Ag Beta-Carotin enthaltende Gelatine
EP0272336A1 (de) * 1986-12-18 1988-06-29 Kurt H. Prof. Dr. Bauer Gegenüber Lichteinfluss stabilisiertes Nifedipin-Konzentrat und Verfahren zu seiner Herstellung

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DATABASE WPIL Section Ch, Week 8108, 17 December 1980 Derwent Publications Ltd., London, GB; Class B04, AN 81-12795D & JP-A-55 161 863 (PARKE DAVIS & CO) *

Also Published As

Publication number Publication date
YU127191A (sh) 1994-05-10
FI913493A0 (fi) 1991-07-19
CY1840A (en) 1996-03-08
IL98894A0 (en) 1992-07-15
FI913493A (fi) 1992-01-21
SE9102160L (sv) 1992-01-21
BE1006829A3 (fr) 1995-01-03
ES2039177B1 (es) 1994-03-16
ZA915677B (en) 1993-03-31
JPH04253924A (ja) 1992-09-09
GB2246072A (en) 1992-01-22
GR1002175B (en) 1996-03-07
DK137591A (da) 1992-01-21
DK137591D0 (da) 1991-07-19
SE9102160D0 (sv) 1991-07-10
IT1250681B (it) 1995-04-21
CA2047482A1 (en) 1992-01-21
CZ280064B6 (cs) 1995-10-18
ES2039177A1 (es) 1993-09-01
ITMI912002A1 (it) 1993-01-19
CH681960A5 (el) 1993-06-30
ITMI912002A0 (it) 1991-07-19
DE4124081A1 (de) 1992-01-23
GB9115693D0 (en) 1991-09-04
HUT59592A (en) 1992-06-29
FR2664814B1 (fr) 1995-05-24
TW203012B (el) 1993-04-01
FR2664814A1 (fr) 1992-01-24
KR920002162A (ko) 1992-02-28
CS222291A3 (en) 1992-02-19
NL9101268A (nl) 1992-02-17
YU47573B (sh) 1995-10-03
HU904564D0 (en) 1990-12-28
GB2246072B (en) 1994-06-15

Similar Documents

Publication Publication Date Title
CA2109623A1 (en) Process for solubilizing difficultly soluble pharmaceutical actives
FR2678169B1 (fr) Nouvelles compositions pharmaceutiques comprenant une cyclosporine, pour l'administration par voie orale.
ITRM910696A0 (it) Composizioni farmaceutiche per l'applicazione per via nasale.
IT1201087B (it) Bifosfonati farmacologicamente attivi,procedimento per la loro preparazione e relative composizioni farmaceutiche
NL194821B (nl) Farmacologisch actieve catecholderivaten en samenstellingen ervan.
DE3788244D1 (de) Pharmakologisch wirksame 3-substituierte 1,5-Diaryl-pyrazole und Verfahren zu ihrer Herstellung.
FR2677984B1 (fr) Derives d'imidazoline n-substitues, leur preparation, les compositions pharmaceutiques en contenant.
FI945081A (fi) Stabiili hydratoitu kefalosporiinikuivajauhe oraaliseen suspensioformulaatioon
TR199801861T2 (xx) Farmas�tik olarak yararl� bile�imler.
IT8219947A0 (it) Complessi platino-diamminici eprocedimento per la loro preparazione nonche' formulazioni farmaceutiche antitumorali contenenti tali complessi.
DE69231663T2 (de) Polysaccharid-protein-konjugate
IT1190824B (it) Composizione farmaceutica contenente 24,25-diidrossicolecalciferolo come ingrediente attivo
BR9509975A (pt) Formulação farmacêutica
GR910100319A (el) Μέ?οδος για την παρασκευή στερεών συν?έσεων περιλαμβανουσών ευαισ?ητοποιημένο εις το φως και δυσκόλως υδατοδιαλυτό ενεργό συστατικό.
DK408083A (da) Isoquinolinderivater, deres fremstilling og anvendelse
SE8302979L (sv) Piperazinderivat, deras framstellning och farmaceutiska kompositioner innehallande dessa
IT8621097A1 (it) Derivato di timo attivo per via orale, procedimenti per la sua preparazione e relative composizioni farmaceutiche
SE8306225D0 (sv) 2-piperazinyl-quinazoline derivatives, their production and pharmaceutical compositions containing them
CA2129676A1 (en) Dextromethorphan Antitussive Compositions
BE890311A (fr) Nouvelles compositions pharmaceutiques a base d'un derive de la 1,4-dihydropyridine
RU93047049A (ru) Новые производные фосфолипидов
PT989994E (pt) Derivados de estreptograminas, a sua preparacao e as composicoes que os contem
PT796256E (pt) Novos processos de preparacao da ranitidina
SE9001592D0 (sv) A therapeutical composition
IT1206513B (it) Composizioni farmaceutiche adattivita'antibiotica-immunostimolante.